ASCP CHEMISTRY SECTION
PRACTICE SOLUTION PACK 2026
COMPLETE TESTED QUESTIONS
AND CORRECT ANSWERS GRADED
A+
◉ In an standard electrophoretic separation, what zone appears first
(anodal end) on the densitometric pattern?
A: Albumin
B: A1-globulins
C: A2-globulins
D: B-globulins
**This is Level 2 Question**. Answer: A
◉ Which of the following cardiovascular risk markers is a more
sensitive version of a test that is used to assess inflammation?
A: Oxidized-LDL
B: HS-CRP
C: ApoB/ApoA1
D: LpPLA2
, **This is Level 2 Question**. Answer: B
◉ How does Aspirin (salicylic acid) affect PLT function?
A: Inhibiting cyclooxygenase
B: Activates lipids
C: Inhibiting carbohydrates
D: Activating nucleic acid
**This is Level 2 Question**. Answer: A
◉ A patient has optimal LDL & HDL cholesterol values, but a HS-CRP
test shows a value of 12mg/L (low cardiovascular risk <1.0mg/L). Which
of the following situations is most likely?
A: The patient has a marked lipid problem such as metabolic syndrome
B: The patient has not been fasting
C: The patient has a underlying acute inflammation process
D: The patient has been drinking too much water before the specimen
was collected, therefore diluting the LDL & HDL values
**This is Level 3 Question**. Answer: C
PRACTICE SOLUTION PACK 2026
COMPLETE TESTED QUESTIONS
AND CORRECT ANSWERS GRADED
A+
◉ In an standard electrophoretic separation, what zone appears first
(anodal end) on the densitometric pattern?
A: Albumin
B: A1-globulins
C: A2-globulins
D: B-globulins
**This is Level 2 Question**. Answer: A
◉ Which of the following cardiovascular risk markers is a more
sensitive version of a test that is used to assess inflammation?
A: Oxidized-LDL
B: HS-CRP
C: ApoB/ApoA1
D: LpPLA2
, **This is Level 2 Question**. Answer: B
◉ How does Aspirin (salicylic acid) affect PLT function?
A: Inhibiting cyclooxygenase
B: Activates lipids
C: Inhibiting carbohydrates
D: Activating nucleic acid
**This is Level 2 Question**. Answer: A
◉ A patient has optimal LDL & HDL cholesterol values, but a HS-CRP
test shows a value of 12mg/L (low cardiovascular risk <1.0mg/L). Which
of the following situations is most likely?
A: The patient has a marked lipid problem such as metabolic syndrome
B: The patient has not been fasting
C: The patient has a underlying acute inflammation process
D: The patient has been drinking too much water before the specimen
was collected, therefore diluting the LDL & HDL values
**This is Level 3 Question**. Answer: C
